Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nomination Committee in Paradox Interactive AB appointed

In accordance with the decision taken by Paradox Interactive AB's Annual General Meeting 2021, the three largest shareholders in the company have the right to each appoint a member of the Nomination Committee. In addition, the Chairman of the Board shall be a member of the Nomination Committee. The three largest shareholders in the company have now each appointed a member, whereby the Nomination Committee for Paradox Interactive AB's Annual General Meeting 2022 has the following members. · Per Håkan Börjesson (Chairman of the Committee), appointed by Investment Aktiebolaget Spiltan

Making sustainable and profitable savings easier

Would you like to contribute to the climate transition while helping your savings grow? The UN trade organisation estimates that annual investments in the region of USD 5-7 trillion is needed to reach the Sustainable Development Goals in the 2030 Agenda for Sustainable Development, including measures aimed at combating climate change. “Investing in a sustainable manner should be both easy and profitable,” says Rebecca Jansson at Handelsbanken Fonder.At present, an estimated one out of three investors choose sustainable funds, according to a survey by the Swedish Investment Fund

Elicera Therapeutics enters agreement with BioNTech for contract manufacturing of viral vectors for CAR T-cell therapy

Gothenburg, November 9, 2021 - Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company that develops immunooncological treatments focusing on CAR T-cells and oncolytic viruses, announced today that it has entered into an agreement with BioNTech for contract manufacturing regarding viral vectors for the company's CAR T-cell therapy, ELC-401.BioNTech IMFS is a contract development and manufacturing organization in Germany that specializes in the industrialization of cell and gene therapies such as virus vectors and cell products. Elicera Therapeutics has entered into an

Kanthal signs licensing agreement regarding MW-scale gas heating solution

Swedish companies Kanthal and Nycast enter an exclusive licensing agreement regarding a large-scale electric gas heating solution developed by Nycast.Kanthal announced today that the company has signed an exclusive licensing agreement with Nycast, a Swedish company that develops electric process gas heating solutions. Under the agreement, Kanthal has the exclusive right to use Nycast’s technology for heating large amounts of process gas at high pressure up to 1,100°C/2,012°F. The technology is a key component for industries with a need to heat high volumes of process gas to high

Mandatory notification of trade - Primary insider

Arild Ingar Moe, EVP and MD NRC Norway, has today purchased 50,000 shares in NRC Group ASA at an average price of NOK 20.06 per share. After the purchase, Arild Ingar Moe holds 252,252 shares in NRC Group ASA. Please refer to the attached document for further details of the transaction. This information is subject to the disclosure requirements in Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section § 5-12.

Mandatory notification of trade – primary insider

The following primary insider in Multiconsult ASA has purchased shares in Multiconsult ASA:Sverre Hurum, Board member in Multiconsult ASA has on 11 November 2021 purchased 6 000 shares in Multiconsult ASA purchased at an average price of NOK 154.5034 per share and will after the transaction hold 21 000 shares in Multiconsult ASA.In addition, Havgatt AS holds 866 shares in Multiconsult. Mr. Hurum owns 50% of the shares in Havgatt AS, the remaining 50% is owned by a related party to Mr. Hurum.For further information, please contact:    Investor relations:      Pål-Sverre Jørgensen,

Wyld Networks to collaborate with AgriSound on beehive monitoring pilot

Wyld Networks today announces a partnership with AgriSound, the acoustic technology innovators, to develop solutions to aid in the maintenance and optimization of the pollination environment.By combining acoustic technology with environmental sensors, AgriSound have developed a range of innovative products that aid in maintaining an optimal pollination environment, necessary not just for the survival of our future pollinators, but to support agricultural productivity and promote the health of the planet.  Without pollinators, especially bee colonies, 70% of all food crops would be at

Everysport Media Group recruits Lisa Villman as new CFO

Everysport Media Group AB (publ.) (ESMG) has recruited Lisa Villman as new Chief Financial Officer (CFO). Lisa comes most recently from Voi and will begin her new role at ESMG in January. Current CFO Alexander Rödström will also take up his new role as Chief Operating Officer (COO) for the business area Everysport Media Lisa Villman comes most recently from Voi and has extensive experience of leading roles in the financial area. She has previously been Accounting Manager at ESMG and before that had a similar position at MAG Interactive. - I am very happy to welcome Lisa back

BERGENBIO RECEIVES FDA FAST TRACK DESIGNATION FOR BEMCENTINIB IN STK11-MUTATED ADVANCED/METASTATIC NON-SMALL LUNG CANCER (NSCLC)

Bergen, Norway, 9 November 2021 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, today announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for bemcentinib in combination with an anti-PD-(L)1 agent as treatment for patients with STK11 altered advanced/metastatic NSCLC patients without actionable mutations. Fast Track designation is intended to facilitate the development and review of drugs used to treat serious conditions and to fill an unmet medical

BERGENBIO PRESENTS PRE-CLINICAL AND CLINICAL DATA ON BEMCENTINIB IN STK11-POSITIVE NSCLC AT SITC ANNUAL MEETING 2021

Bergen, Norway, 9 November 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, is pleased to announce that it will deliver an e-poster presentation at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting, taking place online from 10th-14th November 2021. The e-poster presentation provides pre-clinical and clinical data suggesting that bemcentinib restored response to anti-PD-1 treatments in non-small cell lung cancer (NSCLC) patients harboring STK11 mutations. STK11 is an

Targovax announces two posters at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oslo, Norway, 9 November 2021 - Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that the posters being presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting now are available at the Company’s website.Both posters are scheduled for presentation 13 November 2021 at the SITC congress. Poster A randomised open-label phase I/II study adding ONCOS-102 totitle: pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 24-

VibroSense Dynamics AB signs a Framework Agreement with a large Chinese company group in medical healthcare

VibroSense Dynamics AB (VibroSense) has signed a Framework Agreement with Genertec Universal Medical Group (UMCARE), a subsidiary of China General Technology Group (Genertec), which is China's 42nd largest central State Owned Enterprise. The framework agreement concerns the distribution of VibroSense's product VibroSense Meter® II, with the application Diabetes Foot Screening in the Chinese market.To speed up the process, the parties have divided the negotiations into different parts, where the framework agreement sets the context for future cooperation. This is the first of three

Invitation to interim report livestream November 16, 2021

Paradox Interactive hereby invite you to a livestream in connection with the publication of the company’s interim report for January to September for the fiscal year 2021. Fredrik Wester, CEO, and Alexander Bricca, CFO, will host the livestream on Paradox Interactive’s YouTube channel, present the quarter’s results, and answer questions related to the report and the company’s financial performance. Date: November 16 2021Time: 12:00 PM CET Link: https://youtube.com/paradoxinteractive The interim report will be published at 08:00 CET on November 16 and will be available at https://

Giedrius Bandzevicius new CEO of Rimi Baltic – Edgar Sesemann to retire

ICA Gruppen today appointed Giedrius Bandzevicius as the new CEO of Rimi Baltic. He succeeds Edgar Sesemann, who after 14 years with RIMI and a total of 23 years with ICA Gruppen, has decided to retire. Giedrius Bandzevicius is currently country manager for Rimi in Lithuania, a role he has held since 2017.“I am very happy to welcome Giedrius Bandzevicius as new CEO of Rimi Baltic. Giedrius has played an important part in RIMI Lithuania’s strong performance in recent years, and I look forward to working together with him in the ICA Gruppen Management Team,” says Per Strömberg, CEO of ICA

BioStock: PolarCap provided during IFAF European final

PolarCool’s brain cooling device PolarCap System for treating concussions is quickly gaining popularity across different sports and top leagues across Europe. Most recently, the device was used during the American Football European Championship final, where Sweden played against Italy. To learn more about how the device was introduced to the Swedish national team, BioStock got in touch with PolarCool’s Service and Delivery Manager Eric Rennermalm, who is responsible for establishing PolarCap in Sweden.Read the interview with Eric Rennermalm at biostock.se: https://www.biostock.se/en/2021/

Management Change in Nordic Iron Ore AB (publ)

Markus Karlsson leaves his role as project director in Nordic Iron Ore AB. Karlsson has been hired on a consulting basis and performed the work part-time. The recruitment of a new project director has begun. Meanwhile, Markus Karlsson's duties will be undertaken by Hans Thorshag, technical director, and Paul Marsden, advisor in product development and marketing. Markus Karlsson comments: “I have worked with NIO since 2014 and am grateful to have been able to take part in this exciting journey. However, the time is now ripe to concentrate on other challenges in the mining industry.

InDex Pharmaceuticals gets new patent for cobitolimod granted in the US

November 9, 2021 – InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod has been granted by the United States Patent and Trademark Office (USPTO). The patent provides protection for the use of certain dosage regimens of cobitolimod for treating inflammatory bowel disease, including the 250 mg dose which was successful in the phase IIb study CONDUCT.The patent, entitled Cobitolimod for use in the treatment of inflammatory bowel disease (patent number 11166975), will provide an exclusivity period until May 2038, with the

Best Mobile Casinos USA 2022 - Play Safely on the Go

In recent years, the mobile casino industry has exploded, resulting in a slew of new real-money casinos that welcome mobile play. You may end up surfing the web aimlessly trying to discover one that suits your gaming preferences - so, how do you find the best mobile casinos USA worth your time? Have no fear — that's why we're here. We've been to the bottom of the gambling ocean and back to provide our readers with a list of top mobile casinos in the United States. We have a lot of expertise and experience working on the web, so we're able to spot a questionable business from a mile

The Switch – a new green podcast

November 9 sees the launch of a new podcast dedicated to sustainability and clean energy. The name is The Switch and the aim is to present serious issues in an entertaining format. The Switch is intended as a platform for everybody involved in and interested in the switch towards a green industry. The show is produced by Baseload Capital, DNB, and Energy Disruptors. More than a podcast “The Switch is going to be more than a podcast”, says Kristina Hagström Ilievska, CMO at Baseload Capital. “We’re creating a fast-paced, broad, and entertaining show with a wide range of

REPORT ON BOARD MEMBER’S TRANSACTIONS IN DAMPSKIBSSELSKABET NORDEN A/S’ SHARES

ANNOUNCEMENT NO. 82 - 9 NOVEMBER 2021 Under Article 19 of the Market Abuse Regulation Dampskibsselskabet NORDEN A/S is required to report transactions in Dampskibsselskabet NORDEN A/S’ shares by persons discharging managerial responsibilities and their close relatives. Name: Benedicte Hedengran WegenerReason: Reporting duty, board member (employee elected)Issuer: Dampskibsselskabet NORDEN A/SISIN code: DK0010269844Instrument: SharesTransaction: Sale of shares

ZINZINO AB (PUBL): Zinzino announces the launch of South Africa as next step in their global expansion

Zinzino is very proud to announce the launch of its business in South Africa on November 9, 2021, as a strategic part of the company’s global expansion strategy.After several years of preparing the launch of the South African market and having carried out multiple country establishment processes in recent years, Zinzino has learned the importance of ensuring thorough preparatory work and adapting to the local conditions in each market. Profitable growth is an important business strategy for the e-commerce-based health tech company Zinzino. During 2020 the company sales target was

Power production in October 29.1 GWh

Slightly weaker wind conditions than normal in October resulted in a power production of 29.1 GWh, compared to the month’s budget of 33.3 GWh. Halmstad, 9 November 2021 ARISE AB (publ) For further information, please contact: Per-Erik Eriksson, CEO Arise AB, +46 702 409 902 This information is information that Arise AB is obliged to make public pursuant to the EU MarketAbuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 11.30 CET on 9 November, 2021. Regarding information about how we process your

Hemnet on the housing market in October

· Fewer buyers believe in rising property prices · Lower apartment supply than in October 2020 · Somewhat longer sales times compared to last spring Housing market activity remained high in October. There has been a high number of property sales compared to previous years, although this is now seasonally slowing down in the autumn. The share of buyers expecting prices to rise over the next six months fell by 3 percentage points in November’s survey, from 38 percent to 35 percent, compared with the corresponding figure for October. At the same time, the share of people who say

Interim report January – September 2021

Continued high rate of acquisition and good operating profitJuly – September 2021 · Net sales increased by 21.0 percent to SEK 1,989 (1,643) million. Organic growth, adjusted for currency effects, was 2.2 (–2.7) percent. · EBITA increased to SEK 171 (140) million, which corresponds to an EBITA margin of 8.6 (8.5) percent. · Cash flow from operating activities for the period was SEK –42 (90) million. · Six acquisitions were made during the quarter, which, on an annual basis, contribute an estimated total sales of SEK 399 million. · Earnings per share for the period amounted

There are no items matching the current filter
There are no more items matching the current filter
Back to top